Share

ARMYDA SWITCH 2

ARMYDA SWITCH 2 - Prasugrel versus ticagrelor versus clopidogrel in ACS patients

Project objectives

A single-center, randomized study comparing three antiplatelet therapy strategies (ticagrelor, prasugrel, and clopidogrel) in patients with acute coronary syndrome.

Start and end date

December 2012 - ongoing

Project Manager

Dr. Giuseppe Patti - Local Principal Investigator

Prof. Germano Di Sciascio

Coordinating institution of the project

Università Campus Bio-Medico di Roma

QUICK LINKS
magnifiercrossmenuchevron-downchevron-leftchevron-right